Education
About Us
Working with TipRanks
Follow Us
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Total Valuation
Cosmo Bio Co., Ltd. has a market cap or net worth of ¥7.59B. The enterprise value is ¥5.29B.
Market Cap¥7.59B
Enterprise Value¥5.29B
Share Statistics
Cosmo Bio Co., Ltd. has 6,048,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,048,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Cosmo Bio Co., Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.01%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)2.01%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee61.87M
Profits Per Employee1.93M
Employee Count174
Asset Turnover0.85
Inventory Turnover6.42
Valuation Ratios
The current PE Ratio of Cosmo Bio Co., Ltd. is 22.1. Cosmo Bio Co., Ltd.’s PEG ratio is 0.70.
PE Ratio22.1
PS Ratio0.69
PB Ratio0.79
Price to Fair Value0.79
Price to FCF20.26
Price to Operating Cash Flow0.00
PEG Ratio0.70
Income Statement
In the last 12 months, Cosmo Bio Co., Ltd. had revenue of 10.77B and earned 336.00M in profits. Earnings per share was 59.26.
Revenue10.77B
Gross Profit3.70B
Operating Income342.00M
Pretax Income504.00M
Net Income336.00M
EBITDA509.00M
Earnings Per Share (EPS)59.26
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Cosmo Bio Co., Ltd. pays an annual dividend of ¥25, resulting in a dividend yield of 4.57%
Dividend Per Share¥25
Dividend Yield4.57%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change32.84%
50-Day Moving Average1.32K
200-Day Moving Average1.21K
Relative Strength Index (RSI)68.23
Average Volume (3m)81.79K
Important Dates
Cosmo Bio Co., Ltd. upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Cosmo Bio Co., Ltd. as a current ratio of 5.23, with Debt / Equity ratio of 0.21%
Current Ratio5.23
Quick Ratio4.46
Debt to Market Cap<0.01
Net Debt to EBITDA-5.36
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cosmo Bio Co., Ltd. has paid 170.00M in taxes.
Income Tax170.00M
Effective Tax Rate0.34
Enterprise Valuation
Cosmo Bio Co., Ltd. EV to EBITDA ratio is 9.21, with an EV/FCF ratio of 12.81.
EV to Sales0.44
EV to EBITDA9.21
EV to Free Cash Flow12.81
EV to Operating Cash Flow7.88
Balance Sheet
Cosmo Bio Co., Ltd. has ¥3.19B in cash and marketable securities with ¥20.00M in debt, giving a net cash position of ¥3.17B billion.
Cash & Marketable Securities¥3.19B
Total Debt¥20.00M
Net Cash¥3.17B
Net Cash Per Share¥524.47
Tangible Book Value Per Share¥1.75K
Margins
Gross margin is 34.39%, with operating margin of 3.18%, and net profit margin of 3.12%.
Gross Margin34.39%
Operating Margin3.18%
Pretax Margin4.68%
Net Profit Margin3.12%
EBITDA Margin4.73%
EBIT Margin3.18%
Analyst Forecast
The average price target for Cosmo Bio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.49%
EPS Growth Forecast-32.16%